Compare AbCellera Biologics Inc (ABCL) vs Packaging Corporation of America (PKG) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AbCellera Biologics Inc vs Packaging Corporation of America — how do they compare? AbCellera Biologics Inc trades at $7.16 (market cap $2.35B), while Packaging Corporation of America trades at $225.58 (market cap $20.71B). The key difference: Packaging Corporation of America is far larger — about 8.8× AbCellera Biologics Inc's market cap, and Packaging Corporation of America pays a 2.58% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | PKG | |
|---|---|---|
Market Cap | $2.35B | $20.71B |
Sector | Health | Technology |
52-Week High | $8.12 | $246.31 |
52-Week Low | $2.78 | $191.41 |
Enterprise Value | $1.99B | $24.53B |
Dividend Yield | — | 2.58% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AbCellera Biologics (ABCL) trades at $7.69, down 5.18% today, with a bullish technical signal from moving averages but overbought RSI readings. The company reported a net loss of -$146.41M in 2025, with negative margins, though revenue grew to $75.13M. Recent news highlights a major collaboration with Jazz Pharmaceuticals worth up to $876M, potentially boosting future revenue streams. Analyst consensus is strongly bullish with a $9.67 price target, indicating 25.7% upside.
The outlook hinges on execution of new partnerships and pipeline progress, particularly ABCL635 Phase 2 data expected in Q3 2026. Key risks include persistent cash burn, high valuation multiples despite losses, and biotech sector volatility. Investors should weigh the strong analyst support against fundamental challenges and the stock's current technical overbought condition.
Packaging Corporation of America (PKG) trades at $236.39, down 0.76% on the day, with a bullish technical signal from moving averages and neutral oscillators. The company reported a Q1 2026 EPS beat of $2.40 versus $2.14 expected, with revenue growth to $2.4 billion. Recent news highlights a 20% dividend increase to an annual $6.00 per share and upcoming Q2 2026 earnings call on July 23, 2026.
PKG presents a mixed outlook with strong profitability metrics like a 16.21% ROE and 8.04% net margin, but faces margin pressure and two recent earnings misses. The consensus price target of $245 suggests modest upside, though risks include input cost inflation and competitive pressures. Institutional sentiment is cautiously optimistic with 38% buy ratings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Packaging Corporation of America
Packaging Corporation of America is a leading producer of containerboard and corrugated packaging products in North America. The company also produces white papers, which include printing and writing papers. PKG operates as an integrated manufacturer, with a strong focus on high-quality and sustainable packaging solutions for e-commerce, food and beverage, and other industrial and consumer markets.
Read more on PKG →
